Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 866 posts found.

NICE dementia guidelines not being followed

January 15, 2010
NHS, NHS trusts, NICE, dementia

Few NHS trusts are following NICE’s 2006 guidelines on dementia, according central government auditor the National Audit Office. A NAO …

News

NICE issues schizophrenia commissioning guide

January 14, 2010
NICE, commissioning, schizophrenia

NICE has published a commissioning guide to help primary and secondary care teams recognise, treat and manage adult schizophrenia. The …

News
Shire's ADHD website

Digital Pharma: Byte-sized roundup

January 8, 2010
Medical Communications Diabetes UK, NICE, Shire, ViiV, digital pharma, doctors.net, iphone

Includes online petition against NICE decision, Shire brings ADHD to Twitter, ViiV joins Twitter, Doctors.net.uk launches iPhone app and Diabetes …

News

NICE says no to Multaq

January 8, 2010
Sales and Marketing Multaq, NICE, Sanofi

NICE has rejected Sanofi-Aventis’ new anti-blood clot treatment Multaq (dronedarone) for use on the NHS because of its cost. According …

News
Andrew-Dillon

NICE chief executive knighted in New Year’s honours

January 6, 2010
Andrew Dillon, NHS, NICE, UK, appointment

Andrew Dillon, chief executive of the National Institute for Health and Clinical Excellence (NICE), has been knighted in the 2010 …

Appointment
NICElr

NICE still saying ‘no’ to Roche’s RoActemra

December 17, 2009
Sales and Marketing NICE, RoActemra, Roche

Roche will have to present a stronger case for arthritis drug RoActemra in order to gain approval, according to NICE. …

News

Mental health support programme launched

December 14, 2009
NICE, mental health

A government programme offering workplace support for people with mental health issues has been launched.The idea is to allow sufferers …

News
NICE's Twitter account

Digital Pharma: Byte-sized roundup

December 4, 2009
Medical Communications Abbott, GE Healthcare, HES, NICE, Twitter, digi, digital pharma

Last week it was the ABPI that joined Twitter this week it’s UK cost effectiveness watchdog

News

Plan to bypass NICE put out for consultation

December 1, 2009
Sales and Marketing ABPI, Drayson, NICE

  The UK government is seeking industry input on its proposed pilot scheme to improve patient access to innovative drugs …

News

Janssen-Cilag wins NICE approval for psoriasis drug Stelara

September 23, 2009
Sales and Marketing JJ, NICE, Stelara

 NICE has approved Janssen-Cilag’s Stelara as a treatment option for adults with moderate to severe plaque psoriasis.Part of the process …

News

Industry cautions over probe into use of NICE approved drugs

September 10, 2009
Sales and Marketing NICE, hc

The UK pharma industry has urged caution over data collected on the use of NICE-approved drugs on the NHS that …

News

NICE backs limited use of Lilly’s Plavix rival

September 7, 2009
Research and Development Efient, NICE

 NICE has recommended Lilly and Daiichi’s Efient for use on the NHS, giving the blood-thinner drug a boost in its …

News

NICE criticised for rejection of kidney cancer drugs

August 27, 2009
Research and Development, Sales and Marketing Kidney cancer, NICE, Nexavar

Three treatments for advanced kidney cancer have been rejected by NICE, sparking criticism from pharma companies and patient groups.The drugs …

News

Obstacles remain for patients with blood cancers

August 20, 2009
Research and Development, Sales and Marketing NICE, blood cancer

News

Doubts about funding for ‘Innovation Pass’

August 10, 2009
Research and Development, Sales and Marketing ABPI, NHS, NICE

The new fast-tracking system announced to help accelerate uptake of innovative new treatments in the UK, could be held back …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026